A clinical study of BN201
Phase of Trial: Phase I
Latest Information Update: 03 Apr 2017
At a glance
- Drugs BN 201 (Primary)
- Indications Neuromyelitis optica
- Focus Adverse reactions
- 03 Apr 2017 New trial record
- 29 Mar 2017 According to a Spiral Therapeutics media release, it is expected to receive Clinical Trial Authorization for BN201 in the UK in Q2 2017.
- 29 Mar 2017 According to a Spiral Therapeutics media release, Bionure plans to start this study in 2017.